Charles River Laboratories (CRL) Tops Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $273.00 -1.92%
Revenue Growth %: -4.3%
Financial Fact:
Interest expense: -7.08M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -4.3%
Financial Fact:
Interest expense: -7.08M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q1 EPS of $0.70, $0.05 better than the analyst estimate of $0.65. Revenue for the quarter came in at $286 million versus the consensus estimate of $286.21 million.
Charles River Laboratories reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Charles River Laboratories reaffirmed FY2012 guidance.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- RUM Group to raise Northern Data stake to ~98% via share purchase
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
